Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors
Clinical trial NCT06059508 · UNKNOWN
Trial details
- NCT number
- NCT06059508
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-25
- Primary completion
- 2025-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.